Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Pain Patch market size in 2023 is 4800.0 million US dollars, and it is expected to be 6488.5 million US dollars by 2030, with a compound annual growth rate of 4.40% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Pain Patch market include NEXGEL, Inc., Viatris, Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., and Grunenthal GmbH. The share of the top 3 players in the Pain Patch market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Pain Patch market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Prescription Medicines accounted for XX% of Pain Patch market in 2023. OTC Medicines share of XX%.
Drug Stores & Retail Pharmacies accounted for XX% of the Pain Patch market in 2023. Hospital Pharmacies accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Pain Patch market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Pain Patch market along with global and country-level forecasts from 2024 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Pain Patch market for 2019-2030.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Pain Patch market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Pain Patch industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
NEXGEL, Inc.
Viatris, Inc.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Grunenthal GmbH
Sorrento Therapeutics, Inc.
Hisamitsu Pharmaceutical Co. Inc.
Endo International PLC
Purdue Pharma L.P.
Amneal Pharmaceuticals, Inc.
Types list
Prescription Medicines
OTC Medicines
Application list
Drug Stores & Retail Pharmacies
Hospital Pharmacies
Online Providers
MARKET COMPETITIVE LANDSCAPE:
The main players in the Pain Patch market include NEXGEL, Inc., Viatris, Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., and Grunenthal GmbH. The share of the top 3 players in the Pain Patch market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Pain Patch market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Prescription Medicines accounted for XX% of Pain Patch market in 2023. OTC Medicines share of XX%.
Drug Stores & Retail Pharmacies accounted for XX% of the Pain Patch market in 2023. Hospital Pharmacies accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Pain Patch market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Pain Patch market along with global and country-level forecasts from 2024 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Pain Patch market for 2019-2030.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Pain Patch market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Pain Patch industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
NEXGEL, Inc.
Viatris, Inc.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Grunenthal GmbH
Sorrento Therapeutics, Inc.
Hisamitsu Pharmaceutical Co. Inc.
Endo International PLC
Purdue Pharma L.P.
Amneal Pharmaceuticals, Inc.
Types list
Prescription Medicines
OTC Medicines
Application list
Drug Stores & Retail Pharmacies
Hospital Pharmacies
Online Providers
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
